Insights into myelodysplastic syndromes from current preclinical models

doi:10.5315/wjh.v5.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8167)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

604

WORD

463

HTML

4514

Figures (1-2)

150

Tables (1-3)

252

Sum=5983

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

828

Download

1356

Sum=2184

Feb 6, 2016 (publication date) through Sep 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Feb 6, 2016; 5(1): 1-22
Published online Feb 6, 2016. doi: 10.5315/wjh.v5.i1.1

Full Size Figure Download Figure

Figure 2 Time-line showing key genetic aberrations identified in myelodysplastic syndromes and published mouse models. MDS: Myelodysplastic syndromes.

Citation: Tan SY, Smeets MF, Chalk AM, Nandurkar H, Walkley CR, Purton LE, Wall M. Insights into myelodysplastic syndromes from current preclinical models. World J Hematol 2016; 5(1): 1-22
URL: https://www.wjgnet.com/2218-6204/full/v5/i1/1.htm
DOI: https://dx.doi.org/10.5315/wjh.v5.i1.1